End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,628 ARS | -2.23% | +3.49% | +34.47% |
07-03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
07-03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
816B | ||||||
634B | ||||||
323B | ||||||
293B | ||||||
238B |